Search
for
Sort by
Research 301–330 of 1000+
- Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia
- JOURNAL SCAN
- Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment
- Testosterone metabolite nonessential for androgen effects
- The Efficacy of Growth Factor Injection in Androgenic Alopecia: A Systematic Review and Meta-Analysis
- Pregnancy and the hair growth cycle: anagen induction against hair growth disruption using Nourkrin<sup>®</sup> with Marilex<sup>®</sup>, a proteoglycan replacement therapy
- Alopecia con patrón femenino. Su importancia en medicina y cirugía estética
- Alopecia con patrón femenino. Su importancia en medicina y cirugía estética
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- No Association between Serum Ferritin Levels >10 μg/l and Hair Loss Activity in Women
- Frontal fibrosing alopecia and lichen planus pigmentosus
- The growth of human scalp hair mediated by visible red light laser and LED sources in males
- Hair loss in older women: supplement to increase scalp hair thickness and reduce hair loss
- The Effects of the Oral Supplementation with a Natural Keratin Hydrolysate (Kera-Diet®) on Hair and Nails: Randomized, Placebo and Benchmark-Controlled Clinical Trial on Healthy Females
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Clinical Trials and Hair Loss
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Response to Ong et al., "Hair-raising costs: evaluating botulinum toxin treatment for androgenetic alopecia."
- Oral zinc sulphate in treatment of patients with thallium poisoning: A clinical therapeutic trial
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Development of Uniform Protocol for Alopecia Areata Clinical Trials
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Comparison between single- versus double-spin prepared platelet-rich plasma injection in treatment of female pattern hair loss: clinical effect and relation to vascular endothelial growth factor
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials